CTOs on the Move

Nuvo Group

www.nuvo-group.com

 
NUVO GROUP- Developing the Future of Pregnancy Nuvo Group is committed to transforming pregnancy care for a new generation. We are focused on developing wearable, sensor-based technologies that utilize big data analytics to drastically improve pregnancy healthcare on a global scale. PregSense™ Meet the next generation solution to prenatal monitoring. PregSense™ is the first and only all-in-one pregnancy monitoring designed for remote monitoring and continuous data collection. The wearable, multimodal and wireless platform simultaneously captures multiple data sets from both the mother and the fetus, providing more insights to doctors and a better experience for expecting mothers. Our Team Nuvo ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.nuvo-group.com
  • 318 East 80th Street Suite 2E
    New York, NY USA 10075
  • Phone: 888.688.6462

Executives

Name Title Contact Details
Amit Reches
Vice President of AI and Information Profile

Similar Companies

LifeScan

LifeScan is a global leader in blood glucose monitoring innovation and digital health technology and has a vision to create a world without limits for people with diabetes and related conditions. More than 20 million people and their caregivers around the world count on LifeScan’s OneTouch brand products to manage their diabetes. Together, LifeScan and OneTouch improve the quality of life for people with diabetes with products and digital platforms defined by simplicity, accuracy, and trust.

Real-Time Radiography

Real-Time Radiography is a Pleasanton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PC Group

PC Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Innovatel

With a growing demand for behavioral health services and a shortage of providers, access to care is challenging. Telepsychiatry is a solution to bridge this gap in care. innovaTel has nationwide network of psychiatrists, nurse practitioners and licensed clinical social workers that connect to organizations virtually through telemedicine.

Specific Diagnostics

Bloodstream infection leading to sepsis is responsible for more than half of all deaths in hospitals and is the most expensive condition treated in hospitals. Mortality rate increases 6% every hour from onset. Therefore, it is critical the right antibiotic treatment is determined quickly. Current methodologies require 3 days to determine the effective antibiotic. Specific Diagnostics has developed a new technology that determines the effective antibiotic in less than 1 day. Specific`s Reveal™ instrument and assay are cost effective and labor-saving allowing clinics to readily deploy the Specific Reveal solution. Specific`s unique patented technology leverages a low-cost small molecule sensor (SMS) array, enabling diagnostic products that simplify workflow and speed time-to-answer at low cost. Specific`s system streamlines lab workflow, reduce costs, and substantially shorten the time from sample arrival to selection of effective therapy, saving patients faced with fast-moving and deadly drug-resistant blood infections. Specific and its founders have written almost 60 peer-reviewed publications, detailing the successful demonstration of the SMS array technology. The Company itself has independently authored over 20 scientific publications and conference abstracts detailing the SMS array powered detection, identification and antibiotic susceptibility testing.